Form 4: NeuroPace CFO Rebecca Kuhn Reports Changes in Beneficial Ownership

Rebecca Kuhn, CFO of NeuroPace Inc, reports multiple transactions involving the disposal of common stock to cover tax obligations, resulting in a decrease in her direct holdings.

Summary

• This Form 4 filing details changes in the beneficial ownership of NeuroPace Inc. (NPCE) stock by Rebecca Kuhn, the company's Chief Financial Officer.
• The report covers transactions from April 22, 2022, to February 20, 2025.
• Kuhn disposed of shares of common stock to satisfy tax obligations related to vesting restricted stock units.
• These transactions are identified by transaction code 'F' in Table I, indicating the payment of tax liability by delivering or withholding securities incident to vesting of restricted stock.
• The price per share at which the shares were disposed of varied across the transactions, ranging from $2.98 to $17.50.
• As a result of these transactions, Kuhn's direct ownership of NeuroPace common stock decreased from 151,486 shares on April 22, 2022, to 127,662 shares on February 20, 2025.
• The report also notes that Kuhn acquired 12,938 shares pursuant to the NeuroPace, Inc. 2021 Employee Stock Purchase Plan between April 22, 2021 and June 7, 2024.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The document simply reports transactions and doesn't inherently indicate positive or negative performance for the company. The disposals are for tax obligations, which is a common practice.

Positives

• The reporting of these transactions ensures transparency in accordance with SEC regulations.
• Kuhn's participation in the Employee Stock Purchase Plan demonstrates confidence in the company's future.

Negatives

• The repeated disposal of shares, even for tax purposes, could be perceived negatively by some investors, although it is a common practice.

Risks

• While the disposals are for tax obligations, large or frequent sales by insiders could create downward pressure on the stock price.
• Changes in tax laws could affect the frequency and magnitude of these transactions in the future.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's future performance.

Industry Context

Form 4 filings are a standard part of regulatory compliance for publicly traded companies, providing transparency into the trading activities of company insiders. This filing is typical for executives who receive stock-based compensation.

Comparison to Industry Standards

• Monitoring insider transactions is a common practice in the financial industry.
• Comparing Kuhn's transactions to those of CFOs at similar medical device companies (e.g., Medtronic, Boston Scientific) could provide context, but would require separate analysis of their Form 4 filings.
• The frequency and size of disposals to cover tax obligations are generally consistent with industry norms for executives with significant equity compensation.

Stakeholder Impact

• Shareholders may monitor these transactions for insights into management's perspective on the company's value.
• Employees participating in the Employee Stock Purchase Plan are indirectly affected by the overall stock performance.

Key Dates